Roche Diagnostics Reagents

Special Notice Posted

Solicitation number
36C24618Q9604
Agency
Veterans Integrated Service Network 6 Veterans Health Administration, Department of Veterans Affairs
Set-aside
No set-aside

Opportunity facts

Contract number
36C24619P0058 Federal contract award
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing

Notice details come from SAM.gov. Updated .

Notice text

The Department of Veteran Affairs, Veterans Health Administration, Network Contracting Office 6, Hampton VA 23667, intends to negotiate a sole source purchase order for the reagents compatible with the Ventana HE 600, Benchmark, and Benchmark Ultra Systems for the Durham VAMC with Roche Diagnostics Corporation, in accordance with 10 U.S.C. 2304(c)(1) as implemented by FAR 6.302-1 Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
This is not a request for competitive offers and no solicitation is available. Market research has determined that these services are highly specialized are only available from a single source without an unacceptable delay or duplication of cost and no other type of services will satisfy agency requirements. The Government intends to award the contract with an effective date of 1 Oct. 2018 to ROCHE DIAGNOSTICS CORPORATION, 9115 HAGUE RD, INDIANAPOLIS, IN, 46256; Cage Code: 51169.
This purchase order is for reagents compatible with the Ventana HE 600, Benchmark, and Benchmark Ultra Systems for the Durham VAMC, which will be used to deliver accurate and precise total soft tissue slide staining results.
This synopsis announcement is being issued for information purposes only and does not constitute a solicitation or request for competitive proposals. If a firm believes it can meet the Government's requirement, it may identify their interest and capability to the Contracting Officer within five (5) calendar days of this publication by contacting Cole J. Culley via e-mail at Cole.Culley@va.gov. Telephone inquiries will not be accepted. Those interested firms must indicate whether they are large, small, small-disadvantaged, 8(a) or woman owned business and whether they are U.S. or foreign owned. Respondents who submit proprietary data shall clearly mark the data with appropriate markings. The Government will not pay for any information submitted as a result of this synopsis. This synopsis shall not be construed as an obligation on the part of the Government to acquire any products or services..

Attachments

Files attached to this notice, newest first
File Type Posted
36C24618Q9604-001.docx DOCX document

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Roche Diagnostics Reagents This notice · Latest special notice Special Notice
Roche Diagnostics Reagents Original Pre-Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity